ロード中...
Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
Individuals <2 years and ≥50 years of age, as well as those with other specific risk factors, are especially vulnerable to invasive pneumococcal disease (IPD). Conjugate vaccines have been developed against encapsulated bacteria such as Streptococcus pneumoniae to provide improved immune response...
保存先:
| 出版年: | Eur J Clin Microbiol Infect Dis |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4281374/ https://ncbi.nlm.nih.gov/pubmed/25149825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10096-014-2208-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|